Dose finding in drug development.
From MaRDI portal
Publication:2488571
DOI10.1007/0-387-33706-7zbMath1129.62106OpenAlexW2280050921MaRDI QIDQ2488571
No author found.
Publication date: 24 May 2006
Published in: Statistics for Biology and Health (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.1007/0-387-33706-7
Applications of statistics to biology and medical sciences; meta analysis (62P10) Proceedings, conferences, collections, etc. pertaining to statistics (62-06)
Related Items (23)
Efficient Algorithms for Optimal Designs with Correlated Observations in Pharmacokinetics and Dose-Finding Studies ⋮ Sequential design for binary dose-response experiments ⋮ Testing effect of a drug using multiple nested models for the dose–response ⋮ A Latent Contingency Table Approach to Dose Finding for Combinations of Two Agents ⋮ Pharmacokinetically guided optimum adaptive dose selection in early phase clinical trials ⋮ An algorithm based on semidefinite programming for finding minimax optimal designs ⋮ Bayesian learning of dose-response parameters from a cohort under response-guided dosing ⋮ Escalation with overdose control using ordinal toxicity grades for cancer phase I clinical trials ⋮ Number of patients per cohort and sample size considerations using dose escalation with overdose control ⋮ The Tukey trend test: Multiplicity adjustment using multiple marginal models ⋮ Exact simultaneous confidence intervals for logical selection of a biomarker cut‐point ⋮ Optimal dose‐finding for efficacy–safety models ⋮ Performance Measures in Dose‐Finding Experiments ⋮ Model selection characteristics when using MCP‐Mod for dose–response gene expression data ⋮ Dose finding with escalation with overdose control (EWOC) in cancer clinical trials ⋮ A note on confidence bounds after fixed-sequence multiple tests ⋮ Incorporating a patient dichotomous characteristic in cancer phase I clinical trials using escalation with overdose control ⋮ Cumulative cohort design for dose-finding ⋮ Sequential Designs for Dose Escalation Studies in Oncology ⋮ Implementation of a Bayesian Design in a Dose‐Escalation Study of an Experimental Agent in Healthy Volunteers ⋮ Modeling intracellular delay in within-host HIV dynamics under conditioning of drugs of abuse ⋮ Exact Simultaneous Confidence Bands for Quadratic and Cubic Polynomial Regression with Applications in Dose Response Study ⋮ A comparative study of the dose-response analysis with application to the target dose estimation
Uses Software
This page was built for publication: Dose finding in drug development.
